226 related articles for article (PubMed ID: 29151270)
21. A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a "Glutamine Trap" To Inhibit Lung Cancer Cell Growth.
Wu J; Li Z; Yang Z; Guo L; Zhang Y; Deng H; Wang C; Feng M
Mol Pharm; 2018 Aug; 15(8):3032-3045. PubMed ID: 29939755
[TBL] [Abstract][Full Text] [Related]
22. Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site.
Esslinger CS; Cybulski KA; Rhoderick JF
Bioorg Med Chem; 2005 Feb; 13(4):1111-8. PubMed ID: 15670919
[TBL] [Abstract][Full Text] [Related]
23. Lobetyolin inhibits the proliferation of breast cancer cells
Chen Y; Tian Y; Jin G; Cui Z; Guo W; Zhang X; Liu X
Hum Exp Toxicol; 2021 Dec; 40(12):2074-2086. PubMed ID: 34075790
[TBL] [Abstract][Full Text] [Related]
24. Progesterone inhibits endometrial cancer growth by inhibiting glutamine metabolism through ASCT2.
Guo J; Fan J; Zhang Y; Li M; Jin Z; Shang Y; Zhang H; Kong Y
Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38415405
[TBL] [Abstract][Full Text] [Related]
25. Targeting glutamine transport to suppress melanoma cell growth.
Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JE; Holst J
Int J Cancer; 2014 Sep; 135(5):1060-71. PubMed ID: 24531984
[TBL] [Abstract][Full Text] [Related]
26. Ablation of the
Bröer A; Gauthier-Coles G; Rahimi F; van Geldermalsen M; Dorsch D; Wegener A; Holst J; Bröer S
J Biol Chem; 2019 Mar; 294(11):4012-4026. PubMed ID: 30635397
[TBL] [Abstract][Full Text] [Related]
27. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.
Fuchs BC; Finger RE; Onan MC; Bode BP
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400
[TBL] [Abstract][Full Text] [Related]
28. The involvement of sodium in the function of the human amino acid transporter ASCT2.
Mazza T; Scalise M; Pappacoda G; Pochini L; Indiveri C
FEBS Lett; 2021 Dec; 595(24):3030-3041. PubMed ID: 34741534
[TBL] [Abstract][Full Text] [Related]
29. Characterizing unexpected interactions of a glutamine transporter inhibitor with members of the SLC1A transporter family.
Freidman NJ; Briot C; Ryan RM
J Biol Chem; 2022 Aug; 298(8):102178. PubMed ID: 35752361
[TBL] [Abstract][Full Text] [Related]
30. Disialyl gangliosides enhance tumor phenotypes with differential modalities.
Furukawa K; Hamamura K; Ohkawa Y; Ohmi Y; Furukawa K
Glycoconj J; 2012 Dec; 29(8-9):579-84. PubMed ID: 22763744
[TBL] [Abstract][Full Text] [Related]
31. ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation.
Ren P; Yue M; Xiao D; Xiu R; Gan L; Liu H; Qing G
J Pathol; 2015 Jan; 235(1):90-100. PubMed ID: 25142020
[TBL] [Abstract][Full Text] [Related]
32. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.
Hassanein M; Hoeksema MD; Shiota M; Qian J; Harris BK; Chen H; Clark JE; Alborn WE; Eisenberg R; Massion PP
Clin Cancer Res; 2013 Feb; 19(3):560-70. PubMed ID: 23213057
[TBL] [Abstract][Full Text] [Related]
33. Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells.
Fuchs BC; Perez JC; Suetterlin JE; Chaudhry SB; Bode BP
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G467-78. PubMed ID: 14563674
[TBL] [Abstract][Full Text] [Related]
34. Glutamine transporter ASCT2 was down-regulated in ischemic injured human intestinal epithelial cells and reversed by epidermal growth factor.
Huang Q; Li N; Zhu W; Li Q; Li J
JPEN J Parenter Enteral Nutr; 2007; 31(2):86-93. PubMed ID: 17308248
[TBL] [Abstract][Full Text] [Related]
35. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
36. High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes.
Gegelashvili M; Rodriguez-Kern A; Pirozhkova I; Zhang J; Sung L; Gegelashvili G
Neurochem Int; 2006; 48(6-7):611-5. PubMed ID: 16516348
[TBL] [Abstract][Full Text] [Related]
37. The role of the glutamine transporter ASCT2 in antineoplastic therapy.
Teixeira E; Silva C; Martel F
Cancer Chemother Pharmacol; 2021 Apr; 87(4):447-464. PubMed ID: 33464409
[TBL] [Abstract][Full Text] [Related]
38. Cysteine 467 of the ASCT2 Amino Acid Transporter Is a Molecular Determinant of the Antiport Mechanism.
Scalise M; Pappacoda G; Mazza T; Console L; Pochini L; Indiveri C
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163050
[TBL] [Abstract][Full Text] [Related]
39. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells.
Bröer A; Rahimi F; Bröer S
J Biol Chem; 2016 Jun; 291(25):13194-205. PubMed ID: 27129276
[TBL] [Abstract][Full Text] [Related]
40. AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis.
Tao X; Lu Y; Qiu S; Wang Y; Qin J; Fan Z
Cancer Lett; 2017 Nov; 408():33-42. PubMed ID: 28823958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
